insulinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We have identified three cDNA clones encoding islet amyloid polypeptide (IAPP) or diabetes-associated peptide (DAP) by oligonucleotide screening of a lambda gt10 human insulinoma cDNA library.
|
3053705 |
1988 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.400 |
Biomarker
|
disease |
BEFREE |
Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus.
|
2690069 |
1989 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Several lines of evidence now implicate elevated amylin levels in the pathogenic mechanisms underlying NIDDM, and suggest to us that the obesity which frequently accompanies this syndrome is a result of, rather than a risk factor for, NIDDM.
|
2690958 |
1989 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.400 |
Biomarker
|
disease |
BEFREE |
Amyloid deposits in the islets of Langerhans occur in association with type 2 diabetes mellitus (DM) in humans and cats and consist of a 37-amino-acid polypeptide known as islet amyloid polypeptide (IAPP).
|
2666169 |
1989 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Thus, a species-specific structural motif in the putative amyloidogenic region of IAPP is associated with both amyloid formation and the development of age-related diabetes mellitus.
|
2670595 |
1989 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus.
|
2690958 |
1989 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
Biomarker
|
disease |
BEFREE |
As patients with insulin-treated IDDM frequently experience problems with hypoglycaemia, and as amylin acts to modulate the action of insulin in various tissues, it is possible that amylin deficiency may contribute to morbidity in insulin-treated IDDM, perhaps through the loss of a natural damping mechanism which guards against hypoglycaemia under conditions of normal physiology.
|
2690958 |
1989 |
insulinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We now report the nucleotide sequences of a human insulinoma cDNA encoding a complete IAPP precursor, and of the corresponding parts of the IAPP gene.Two exons, which are approx.
|
2651160 |
1989 |
Obesity
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Several lines of evidence now implicate elevated amylin levels in the pathogenic mechanisms underlying NIDDM, and suggest to us that the obesity which frequently accompanies this syndrome is a result of, rather than a risk factor for, NIDDM.
|
2690958 |
1989 |
Plaque, Amyloid
|
0.100 |
Biomarker
|
disease |
BEFREE |
Amyloid deposits in the islets of Langerhans occur in association with type 2 diabetes mellitus (DM) in humans and cats and consist of a 37-amino-acid polypeptide known as islet amyloid polypeptide (IAPP).
|
2666169 |
1989 |
Hypoglycemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
As patients with insulin-treated IDDM frequently experience problems with hypoglycaemia, and as amylin acts to modulate the action of insulin in various tissues, it is possible that amylin deficiency may contribute to morbidity in insulin-treated IDDM, perhaps through the loss of a natural damping mechanism which guards against hypoglycaemia under conditions of normal physiology.
|
2690958 |
1989 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We have sequenced the islet amyloid polypeptide precursor coding regions of the gene of 25 patients with Type 2 diabetes.
|
2258001 |
1990 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.400 |
Biomarker
|
disease |
BEFREE |
Most evidence to-date suggests that an intrinsic structural motif of IAPP is linked to the amyloidogenicity of IAPP, and that this motif occurs only in those species (e.g., humans and cats) that also develop age-associated or Type 2 diabetes We utilized polymerase chain reaction methodology in this study to obtain the IAPP nucleotide and protein sequences of the dog, a species not known to develop islet amyloid.
|
2192709 |
1990 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
The connection between IAPP amyloid formation and diabetes is unknown, but a limited segment of the IAPP molecule, positions 20-29, seems responsible for the aggregation to fibrils.
|
2195544 |
1990 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
The connection between IAPP amyloid formation and diabetes is unknown, but a limited segment of the IAPP molecule, positions 20-29, seems responsible for the aggregation to fibrils.
|
2195544 |
1990 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients.
|
2258001 |
1990 |
insulinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We show that dog IAPP contains the same putative amyloidogenic sequence (GAILS) at residues 24-28 as human and cat IAPP, and that although dogs do not develop islet amyloid they do develop IAPP-derived amyloid in association with neoplastic beta cells (i.e., insulinomas).
|
2192709 |
1990 |
Creutzfeldt-Jakob disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
This sensitive exogenous strong-stop reaction revealed that CJD infectious fractions contained a series of potential retroviral RNAs including apparent transcripts of endogenous hamster IAP genes.
|
2108258 |
1990 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A mutation in or near the islet amyloid polypeptide gene is thus unlikely to be a common cause of Type 2 diabetes.
|
1676684 |
1991 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
No differences in the structure of IAPP or its precursor have been found in individuals with maturity-onset diabetes of the young or type II diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)
|
1999269 |
1991 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes?
|
1999269 |
1991 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes?
|
1999269 |
1991 |
insulinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
IAPP mRNA was confined to the beta-cell phenotype when analyzing the phenotypically stable in vivo tumor lines, MSL-G2-IN (insulinoma) and MSL-G-AN (glucagonoma), and the transgenic mouse islet cell lines, beta-Tc and alpha-Tc.
|
1850107 |
1991 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
IAPP mRNA was confined to the beta-cell phenotype when analyzing the phenotypically stable in vivo tumor lines, MSL-G2-IN (insulinoma) and MSL-G-AN (glucagonoma), and the transgenic mouse islet cell lines, beta-Tc and alpha-Tc.
|
1850107 |
1991 |
Multiple Myeloma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Expression of the MIPP gene parallels that of IAP genes in normal mouse tissues with abundant transcripts present in the placenta and also in the myeloma MOPC-315.
|
1906605 |
1991 |